TG THERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Tg Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Tg Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 156M shares, a 2.92% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 156M +4.42M +2.92% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 155M +3.9M +2.59% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 155M +5.17M +3.46% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 151M +5.04M +3.44% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 151M +6.09M +4.19% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 151M +5.77M +3.98% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 149M +4.85M +3.36% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 146M +3.13M +2.19% Dec 31, 2022 10-K 2024-02-29
Q3 2022 145M +2.41M +1.69% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 145M +2.32M +1.63% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 145M +3.06M +2.16% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 143M +2.67M +1.9% Dec 31, 2021 10-K 2023-03-01
Q3 2021 143M +14M +10.9% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 143M +16.2M +12.8% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 142M +31.3M +28.4% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 141M +31.2M +28.5% Dec 31, 2020 10-K 2022-03-01
Q3 2020 129M +32.3M +33.4% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 127M +33.3M +35.6% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 110M +21.6M +24.4% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 109M +25.5M +30.4% Dec 31, 2019 10-K 2021-03-01
Q3 2019 96.7M +13.7M +16.5% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 93.4M +10.9M +13.2% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 88.6M +11.4M +14.8% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 83.9M +10.7M +14.7% Dec 31, 2018 10-K 2020-03-02
Q3 2018 83M +12.3M +17.4% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 82.5M +14.4M +21.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 77.1M +10.3M +15.4% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 73.2M +16.4M +28.8% Dec 31, 2017 10-K 2019-03-01
Q3 2017 70.7M +15.9M +29.1% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 68.1M +13.6M +25% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 66.8M +12.7M +23.5% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 56.8M +2.73M +5.04% Dec 31, 2016 10-K 2018-03-15
Q3 2016 54.8M +2.21M +4.2% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 54.5M +2.8M +5.42% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 54.1M +6.65M +14% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 54.1M +9.12M +20.3% Dec 31, 2015 10-K 2017-03-16
Q3 2015 52.6M +11.1M +26.7% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 51.7M +13.5M +35.5% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 47.5M +9.95M +26.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 45M +10.6M +31% Dec 31, 2014 10-K 2016-03-15
Q3 2014 41.5M +8.07M +24.1% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 38.2M +11.4M +42.7% Jun 30, 2014 10-Q 2014-07-24
Q1 2014 37.5M +11.2M +42.6% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 34.3M +8.52M +33% Dec 31, 2013 10-K 2015-03-16
Q3 2013 33.4M +13.4M +66.6% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 26.7M +8.68M +48.1% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 26.3M +21.3M +420% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 25.8M +20.8M +410% Dec 31, 2012 10-K 2014-03-07
Q3 2012 20.1M +12.7M +171% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 18.1M +15.5M +595% Jun 30, 2012 10-Q/A 2012-09-07
Q1 2012 5.06M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 5.06M +2.64M +109% Dec 31, 2011 10-K 2013-03-21
Q3 2011 7.4M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 2.6M Jun 30, 2011 10-Q/A 2011-09-14
Q4 2010 2.42M Dec 31, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.